AU2001242876A1 - Compositions suitable for the treatment of damage caused by ischemia/reperfusionor oxidative stress - Google Patents

Compositions suitable for the treatment of damage caused by ischemia/reperfusionor oxidative stress

Info

Publication number
AU2001242876A1
AU2001242876A1 AU2001242876A AU4287601A AU2001242876A1 AU 2001242876 A1 AU2001242876 A1 AU 2001242876A1 AU 2001242876 A AU2001242876 A AU 2001242876A AU 4287601 A AU4287601 A AU 4287601A AU 2001242876 A1 AU2001242876 A1 AU 2001242876A1
Authority
AU
Australia
Prior art keywords
ischemia
oxidative stress
damage caused
reperfusionor
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001242876A
Other languages
English (en)
Inventor
Zandrie Hofman
Hendrik Gerrit Derk Leuvenink
Eduard Christiaan Van Hoorn
Klaske Van Norren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of AU2001242876A1 publication Critical patent/AU2001242876A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
  • Processing Of Meat And Fish (AREA)
  • Heat Treatment Of Articles (AREA)
AU2001242876A 2000-03-22 2001-03-22 Compositions suitable for the treatment of damage caused by ischemia/reperfusionor oxidative stress Abandoned AU2001242876A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL00201051.0 2000-03-22
EP00201051A EP1136073A1 (fr) 2000-03-22 2000-03-22 Compositions destinées pour le traitement des maladies causées par l'ischémie/la reperfusion ou le stress oxydant
PCT/NL2001/000233 WO2001070248A1 (fr) 2000-03-22 2001-03-22 Compositions concues pour le traitement de lesions provoquees par l'ischemie/reperfusion ou le stress oxydatif

Publications (1)

Publication Number Publication Date
AU2001242876A1 true AU2001242876A1 (en) 2001-10-03

Family

ID=8171244

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001242876A Abandoned AU2001242876A1 (en) 2000-03-22 2001-03-22 Compositions suitable for the treatment of damage caused by ischemia/reperfusionor oxidative stress

Country Status (10)

Country Link
US (2) US20040076692A1 (fr)
EP (2) EP1136073A1 (fr)
JP (1) JP2003527434A (fr)
AT (1) ATE316382T1 (fr)
AU (1) AU2001242876A1 (fr)
DE (1) DE60116860T2 (fr)
DK (1) DK1267901T3 (fr)
ES (1) ES2257401T3 (fr)
HK (1) HK1051503A1 (fr)
WO (1) WO2001070248A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7438936B2 (en) * 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
US7416749B2 (en) * 2000-06-12 2008-08-26 Access Business Group International Llc Dietary supplement and related method
US7939115B2 (en) * 2000-06-12 2011-05-10 Access Business Group International Llc Dietary supplement and related method
WO2003041703A2 (fr) * 2001-11-16 2003-05-22 Gho Holding B.V. Methode de traitement des brulures
CN100345593C (zh) * 2002-08-06 2007-10-31 东丽株式会社 用于制备肾脏疾病的治疗或预防药物中的用途
DE10257360A1 (de) * 2002-12-09 2004-07-08 Fresenius Kabi Deutschland Gmbh Gastro-intestinal verabreichbare Formulierung und deren Verwendung
FR2854307A1 (fr) * 2003-04-30 2004-11-05 Jean Morelle Utilisation de complements vegetaux d'origine alimentaire, de proprietes anti-stress oxydatif dans le cadre de l'effort physique, humain ou animal
JP2005097222A (ja) * 2003-08-26 2005-04-14 Toyo Shinyaku:Kk タマネギ発酵物
CA2539485A1 (fr) * 2003-09-19 2005-03-31 N.V. Nutricia Methode et composition de prevention du syndrome des dysfonctionnements multiples d'organes
US7384654B2 (en) 2004-02-05 2008-06-10 Access Business Group International Llc Anti-Allergy composition and related method
US8557831B2 (en) 2004-07-21 2013-10-15 University Of Florida Research Foundation, Inc. Compositions and methods for treatment and prevention of insulin resistance
ES2552108T3 (es) * 2005-03-11 2015-11-25 Howard Florey Institute Pty Ltd Compuestos flavonoides y usos de los mismos
EP1919472B1 (fr) * 2005-07-21 2021-09-01 University of Florida Research Foundation, Inc. Compositions et procédés destinés au traitement et à la prévention de conséquences sur la santé liées à l' hyperuricémie
EP2251024A4 (fr) * 2008-01-23 2011-12-28 Kaneka Corp Médicament d'origine végétale destiné à prévenir ou améliorer l'hyperuricémie
CA2718056A1 (fr) * 2008-03-13 2009-09-17 The Regents Of The University Of California Utilisation d'epicatechine, de derives et de sels de celle-ci, pour assurer une protection cardiaque du myocarde ischemique et ameliorer un remodelage cardiaque a risque
CN102872124B (zh) * 2012-10-27 2013-10-23 南京大学 Houttuynoid A在预防或治疗胰腺纤维化的药物中的应用
CN102872127B (zh) * 2012-10-27 2013-07-17 吴俊华 Houttuynoid C在预防或治疗胰腺纤维化的药物中的应用
JP7401863B2 (ja) * 2020-10-08 2023-12-20 国立大学法人 鹿児島大学 血管攣縮抑制剤、血管攣縮予防剤、血管攣縮予防用経口組成物及び血管攣縮抑制用経口組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2903318B2 (ja) * 1989-04-04 1999-06-07 日研フード株式会社 抗酸化的ストレス物
FR2697159B1 (fr) * 1992-10-22 1995-01-13 Oreal Composition cosmétique ou dermo-pharmaceutique contenant en association un lauroylméthionate d'un amino acide basique et au moins un polyphénol.
FR2699818B1 (fr) * 1992-12-24 1995-02-03 Oreal Composition cosmétique ou pharmaceutique contenant en association un polyphénol et un extrait de gingko.
GB2290487B (en) * 1994-06-23 1998-06-10 John Hunter Dual fuel fluidised bed gasification-combustion system
DE4441279C1 (de) * 1994-11-19 1995-09-21 Abb Management Ag Vorrichtung zur Strombegrenzung
IT1286564B1 (it) * 1996-03-05 1998-07-15 Comiter Trading & Services S R Un prodotto a base di olio extravergine di oliva,olio vergine di oliva od olio di oliva arricchito ed integrato,ed un procedimento per
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US5886029A (en) * 1997-09-05 1999-03-23 Dhaliwal; Kirpal S. Method and composition for treatment of diabetes
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
EP1100539B1 (fr) * 1998-08-06 2002-11-20 Vascular Biotech GmbH Combinaison de principes actifs, en particulier pour la prophylaxie et la therapie de lesions organiques ischemiques et des syndromes de reperfusion
CA2348395C (fr) * 1998-10-29 2009-12-22 Merck Patent Gesellschaft Mit Beschraenkter Haftung Compositions contenant un melange de bioflavonols
DE29908634U1 (de) * 1999-04-09 1999-12-16 Hoensch, Harald, Prof.Dr.med., 64521 Groß-Gerau Nahrungsergänzungsmittel zur Behandlung von Darmerkrankungen
AU5124600A (en) * 1999-04-26 2000-11-10 Imperial Sensus, L.L.C. Granular delivery system
US6291533B1 (en) * 1999-12-22 2001-09-18 Vitamerica, Inc. Dietary supplements for each specific blood type

Also Published As

Publication number Publication date
DE60116860T2 (de) 2006-09-21
EP1136073A1 (fr) 2001-09-26
WO2001070248A1 (fr) 2001-09-27
EP1267901B1 (fr) 2006-01-25
US20060270615A1 (en) 2006-11-30
DK1267901T3 (da) 2006-05-29
EP1267901A1 (fr) 2003-01-02
US20040076692A1 (en) 2004-04-22
ATE316382T1 (de) 2006-02-15
JP2003527434A (ja) 2003-09-16
DE60116860D1 (de) 2006-04-13
EP1267901B9 (fr) 2006-06-28
HK1051503A1 (en) 2003-08-08
ES2257401T3 (es) 2006-08-01

Similar Documents

Publication Publication Date Title
AU2001242876A1 (en) Compositions suitable for the treatment of damage caused by ischemia/reperfusionor oxidative stress
EP2255661A3 (fr) Formulations enterales des compositions polymeres pro-anthocyanidiques à propriétés anti-diarrheiques
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
IL143332A0 (en) Scavenger compounds
MY133996A (en) Compounds for the treatment of ischemia
AU5669298A (en) Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
AU4120699A (en) Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
NZ331104A (en) Phenyl thiazole derivatives that inhibit herpes replication by inhibiting the herpes helicase primase enzyme complex
AU2001275228A1 (en) Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor
WO2002096360A3 (fr) Composes a base d'un sel acide amine permettant de parer aux effets des especes d'oxygene reactif et des radicaux libres
AU6783698A (en) Polyaromatic antiviral compositions
YU24402A (sh) 2'-supstituisani 1,1'-bifenil-2-karbonamidi, postupak za njihovu proizvodnju, njihova primena kao leka kao i farmaceutski preparati koji sadrže ta jedinjenja
WO1997034599A3 (fr) Utilisation de clotrimazole et de composes apparentes dans le traitement de la diarrhee
NO20040153L (no) Synergistisk farmasoytisk kombinasjon for profylakse eller behandling av diabetes
GR3036142T3 (en) Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
AU1816500A (en) Bleaching compositions
AU2001259801A1 (en) 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
AU7669700A (en) Silicon compounds derived from ascorbic acid
WO2002092781A3 (fr) Composes de peptides contrecarrant lessubstances oxygenees et les radicaux libres
AU1040000A (en) Compositions comprising a mixture of bioflavonols
AU2173697A (en) Compositions for the treatment of burns and external ulcers and a process for the preparation thereof
AU6465200A (en) Use of n-methyl bases of ethanolamine for prevention of cell death induced by oxidative stress
EP1419781B8 (fr) Usage odontostomatologique des composés d'origine vegetale à base de racines de rhubarbe (genre rheum) et feuilles d'épinard (spinacia oleracea l.)